Risk factors for imipenem-resistant Pseudomonas aeruginosa in neonatal intensive care units in south China

被引：12
作者：
Rao, Y. B. [1 ,2 ]
Ren, Z. X. [1 ,2 ]
Zhong, J. J. [1 ]
Zhong, X. M. [1 ,2 ]
Cao, B. [3 ]
Chen, D. M. [4 ]
Pan, X. N. [5 ]
Jia, Y. P. [6 ]
Gao, P. M. [7 ]
Yang, B. Y. [8 ]
Zhong, Q. [9 ]
Yang, J. [1 ]
机构：
[1] Guangdong Women & Children Hosp, Dept Neonatol, Guangzhou, Guangdong, Peoples R China
[2] Guang Zhou Med Univ, Guangzhou, Guangdong, Peoples R China
[3] Women & Childrens Hosp Hunan Prov, Dept Neonatol, Changsha, Hunan, Peoples R China
[4] Women & Childrens Hosp Quanzhou, Dept Neonatol, Quanzhou, Fujian, Peoples R China
[5] Women & Childrens Hosp Guangxi Zhuang Autonomous, Dept Neonatol, Nanning, Guangxi, Peoples R China
[6] Womens & Childrens Hosp, Dept Neonatol, Haikou, Hainan, Peoples R China
[7] Women & Childrens Hosp Foshan, Dept Neonatol, Foshan, Guangdong, Peoples R China
[8] Women & Childrens Hosp Zhongshan, Dept Neonatol, Zhongshan, Guangdong, Peoples R China
[9] Women & Childrens Hosp Shenzhen, Dept Neonatol, Shenzhen, Guangdong, Peoples R China
来源：
JOURNAL OF HOSPITAL INFECTION | 2018年 / 98卷 / 03期
关键词：
Neonate; Pseudomonas aeruginosa; Imipenem; Hospital-acquired infection; NOSOCOMIAL INFECTION;
D O I：
10.1016/j.jhin.2017.12.016
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
This multi-centre retrospective study was designed to investigate the risk factors for infection with imipenem-resistant Pseudomonas aeruginosa in neonatal intensive care units (NICUs) in south China. All patients with confirmed P. aeruginosa infection from eight NICUs in south China were divided into two groups: imipenem-susceptible P. aeruginosa and imipenem-resistant P. aeruginosa. Data were analysed using Chi-squared test and logistic regression. In total, 188 medical records were reviewed. On multi-variate logistic analysis, the only independent risk factor was imipenem treatment within two weeks of isolation of P. aeruginosa (odds ratio 6.409, 95% confidence interval 1.926-21.333). (C) 2017 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
引用
收藏
页码：305 / 308
页数：4
相关论文
共 50 条
[11]   Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections [J].
Suarez, Cristina ;
Pena, Carmen ;
Tubau, Fe ;
Gavalda, Laura ;
Manzur, Adriana ;
Dominguez, M. Angeles ;
Pujol, Miquel ;
Gudiol, Francisco ;
Ariza, Javier .
JOURNAL OF INFECTION, 2009, 58 (04) :285-290
[12]   Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital [J].
Sasaki, M ;
Hiyama, E ;
Takesue, Y ;
Kodaira, M ;
Sueda, T ;
Yokoyama, T .
JOURNAL OF HOSPITAL INFECTION, 2004, 56 (02) :111-118
[13]   Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin [J].
Mikura, S. ;
Wada, H. ;
Okazaki, M. ;
Nakamura, M. ;
Honda, K. ;
Yasutake, T. ;
Higaki, M. ;
Ishii, H. ;
Watanabe, T. ;
Tsunoda, T. ;
Goto, H. .
JOURNAL OF HOSPITAL INFECTION, 2011, 79 (03) :267-268
[14]   Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa [J].
Wi, Yu Mi ;
Choi, Ji-Young ;
Lee, Ji-Young ;
Kang, Cheol-In ;
Chung, Doo Ryeon ;
Peck, Kyong Ran ;
Song, Jae-Hoon ;
Ko, Kwan Soo .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
[15]   Recombinase-aided amplification assay for rapid detection of imipenem-resistant Pseudomonas aeruginosa and rifampin-resistant Pseudomonas aeruginosa [J].
Zhou, Yao ;
Shi, Ruiqing ;
Mu, Liang ;
Tian, Linlin ;
Zhou, Mengshan ;
Lyu, Wenhan ;
Chen, Yaodong .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
[16]   Characterization of imipenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates in a Moroccan hospital [J].
Benaissa, Elmostafa ;
Abassour, Tilila ;
Belouad, Elmehdi ;
Maleb, Adil ;
Elouennass, Mostafa .
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2022, 69 (02) :118-126
[17]   In vitro Effects of Various Antimicrobials Alone and in Combinations against Imipenem-Resistant Pseudomonas aeruginosa [J].
Tunyapanit, Wanutsanun ;
Pruekprasert, Pornpimol ;
Laoprasopwattana, Kamolwish ;
Chelae, Sureerat .
SAINS MALAYSIANA, 2019, 48 (05) :1065-1073
[18]   Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases [J].
El-Domany, Ramadan Ahmed ;
Emara, Mohamed ;
El-Magd, Mohammed A. ;
Moustafa, Walaa H. ;
Abdeltwab, Nesma M. .
MICROBIAL DRUG RESISTANCE, 2017, 23 (06) :682-686
[19]   The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study [J].
Carmeli, Yehuda ;
Lidji, Shiri Klarfeld ;
Shabtai, Esther ;
Navon-Venezia, Shiri ;
Schwaber, Mitchell J. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 70 (03) :367-372
[20]   Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections [J].
Baran, Guelseren ;
Erbay, Ayse ;
Bodur, Huerrem ;
Onguru, Pinar ;
Akinci, Esraguel ;
Balaban, Neriman ;
Cevik, Mustafa A. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (01) :16-21
12345